Shares of Walmart-backed Ibotta soared in their market debut, rising more than 30% and giving the digital marketing company a valuation of about $3.55 billion.
Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
